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dextroaortic arch.
③ Other anomalies detected in the fetal cardiovascular casts while
misdiagnosed in echocardiography: pulmonary artery crossover,
double outlet of the morphological left ventricle, abnormal origin of
the left common carotid artery by innominate artery, persistent left
superior vena cava, right atrial isomerism.
CONCLUSIONS ① Prenatal echocardiography has an indispensable
role in the diagnosis of pulmonary artery stenosis/atresia.
② Fetal cardiovascular cast can accurately and vividly represent the
orientation of great vessels and branches, which is helpful to understand
malformations of great vessels and to improve the diagnostic ability.
③ Pulmonary stenosis/atresia is always accompanied with other
cardiovascular abnormalities. More attention should be paid in the
analysis and diagnosis of associated malformations.
④ The comparative study of fetal echocardiography and cardio-
vascular cast on the diagnosis of pulmonary artery stenosis/atresia has
an important value in clinical application, which can offer valuable
information to the families and physicians, and also can evaluate
pregnancy outcome and provide appropriate guidance for further
necessary interventions.GW26-e2332
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OBJECTIVES Mycoplasma pneumoniae (M. pneumoniae) primarily
causes upper respiratory tract infection and atypical pneumonia in
school-aged children. Mycoplasma-associated Cardiac involvement
such as acute myocarditis, or pericarditis isan uncommon complica-
tion occurring in only less than 5% of patients. In this report, We
report one case with acute pericarditis due to M. pneumoniae in our
hospital over 5 year period.
METHODS Retrospective analysis was performed on 60 patients (<14
years old) with serologically conﬁrmed M. pneumoniae presenting to the
emergency department from January 2009 to March 2015. Among them,
one patient developed acute pericarditis due to M. pneumoniae infection.
RESULTS This 8 year old boy was admitted to the emergency
department in July 2009 with a 6 day history of fever up to 38.5C,
cough, wheeze, vomiting and lethargy. He had been started on oral
clarithromycin by pediatric clinic for one day.On the second hospital
day, the patient developed shortness of breath, obvious chest pain,
oliguria and the fever increased up to 39C. His rate of heart was up to
147bpm. Blood pressure was 76/51mmHg. the pericardial friction rub
could be heard at his precordium region and lung auscultation
revealed coarse rhonchi and wheezes. Blood test results showed His
hemoglobin levels at 11.0 g/dL; leukocyte count was 8700/mL; plate-
lets count was 215000/mL; aspartate aminotransferase was 132 IU/L;
alanine transaminase was 145 IU/L; creatinine kinase (CK) was 476 IU/
L; CK-MB was 124 ng/mL; pro-brain natriuretic peptide (pro-BNP) was
5218 pg/mL; lactate dehydrogenase level was 420 IU/L; erythrocyte
sedimentation rate was 14 mm/h; C-reactive protein was 19 mg/L; and
ELISA test forM. pneumoniae IgM was positive (1:800), inﬂuenza virus
(A and B), respiratory syncytial virus, adenovirus, parainﬂuenza virus,
Chlamydia pneumoniae, legionella pneumophila, Coxsackie A, Cox-
sackie B, and echovirus antibodies were negative. Abdominal hep-
atobiliary ultrasound was normal. Chest radiograph showed signs of
bronchopneumonia. Echocardiogram showed mild pericardial effu-
sion, normal left ventricle contractility. Based on these ﬁndings,
mycoplasma pneumonia complicated by acute pericarditis with peri-
cardial effusion were diagnosed. We treated the patient with intra-
venous azithromycin 10 mg/kg/day and intravenous immunoglobulin,
diuretics, dopamine, Antileukotriene agents, nebulized bronchodila-
tors and corticosteroid (ICS). on the next few days, the child’s symp-
toms of lower respiratory tract gradually improved and became
afebrile in four days, CK-MB and pro-BNP had gradually improved to
normal. Pericardial effusion had disappeared in two weeks.
CONCLUSIONS M. pneumoniae may be the pathogen of acute peri-
carditis patients. Appropriate and timely treatment is required.
Serological testing for Mycoplasma pneumoniae should be part of the
routine examination for pericarditis of unknown Origin.GW26-e4631
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OBJECTIVES To describe a series of fetal ductus arteriosus constric-
tion and review the literatures.
METHODS The databases were searched for all cases of ductal
constriction detected during the last 3 years. The following variables
were analyzed: gestational age at diagnosis, indication for echocar-
diography, presence of right ventricular hypertrophy, presence of
tricuspid valve regurgitation, ductal pulsatility index, signs of fetal
heart failure, pregnancy and feto-neonatal outcome, and ductal status
at neonatal echocardiography.
RESULTS Six cases of fetus were presented with tricuspid valve
regurgitation secondary to an S-shaped ductus arteriosus with distal
constriction diagnosed by pulsed Doppler imaging. None of the cases
were secondary to maternal exposure to indomethacin or other non-
steroidal anti-inﬂammatory medications, or structural cardiac
lesions. A review of the recent English literature of similar cases is
presented.
CONCLUSIONS Constriction of the ductus arteriosus can be diag-
nosed prenatally with careful interrogation of the ductal arch using
pulsed Doppler sonography and complete fetal echocardiography.
Close monitoring of the fetus is then warranted to detect development
of right heart failure and to intervene prior to development of
hydrops.RELATED PHARMACEUTICAL CLINICAL RESEARCH
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OBJECTIVES Few studies have investigated the effects of angiotensin
blockades (ABs) on mortality and cardiovascular events of established
patients with atrial ﬁbrillation (AF). Aim of the current study was to
assess the association between ABs treatment and 1-year survival in
patients with AF in real-world clinical practice.
METHODS The present study consecutively enrolled AF patients
presenting to an emergency department at 20 hospitals in China from
November 1, 2008 to October, 31 2011. Multivariate Cox proportional
hazards regression was used on all the patients. End points of the
analyses were all-cause mortality, stroke and major adverse events
(MAE).
RESULTS A total of 2015 AF patients were included in the analysis,
and 42.2% patients received ABs treatment. During 1-year follow-up,
13.8% patients died. In the ﬁnal multivariate Cox proportional models
of predictors for all-cause mortality and stroke, after adjustment for
multiple relevant co-variables, ABs was signiﬁcantly associated with a
lower risk of all-cause mortality (HR: 0.66, 95% CI: 0.50-0.88,
p¼0.004) compared to non-ABs patients. Meanwhile, ABs was not an
independent risk factor for stroke (HR: 0.81, 95% CI: 0.56-1.19, p¼287).
CONCLUSIONS ABs usage was associated with a lower all-cause
mortality in patients with AF, as well as it did not increase the risk of
stroke and MAE incidences.
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OBJECTIVES To present the interim analysis of long-term safety and
effectiveness proﬁles of tadalaﬁl (Adcirca) in daily clinical practice
